Capecitabine is an active agent for the treatment of patients with ovarian cancer previously treated with platinum and taxanes.
Vasey PA, McMahon L, Paul J, Reed N, Kaye SB. A phase II trial of capecitabine (Xeloda) in recurrent ovarian cancer. Br J Cancer. 2003 Nov 17;89(10)
Overview of the Updated NCCN Guidelines on Ovarian Cancer, Journal of Clinical Pathways September 2022
Volume 8 Issue 6
NCCN Ovarian Cancer 2022
Cancer Treatment Today
228 Park Ave S #70464
New York, NY 10003-1502
info@cancertreatmenttoday.org
Tel - 212-372-7263